{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:36:01Z","timestamp":1759937761507,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1124\/dmd.106.013037","type":"journal-article","created":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:50:06Z","timestamp":1177980606000},"page":"1275-1284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Asymmetric Intestinal First-Pass Metabolism Causes Minimal Oral Bioavailability of Midazolam in Cynomolgus Monkey"],"prefix":"10.1016","volume":"35","author":[{"given":"Tomohiro","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.106.013037_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1248\/bpb.28.311","article-title":"Intestinal expression and metabolic activity of the CYP3A subfamily in female rats","volume":"28","author":"Aiba","year":"2005","journal-title":"Biol Pharm Bull"},{"issue":"Suppl 1","key":"10.1124\/dmd.106.013037_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0169-409X(01)00178-8","article-title":"The drug efflux-metabolism alliance: biochemical aspects","volume":"50","author":"Benet","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.106.013037_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2002.12.002","article-title":"Unmasking the dynamic interplay between efflux transporters and metabolic enzymes","volume":"277","author":"Benet","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.106.013037_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.106.013037_bib5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1023\/A:1016169202830","article-title":"Comparison of oral absorption and bioavailability of drugs between monkey and human","volume":"19","author":"Chiou","year":"2002","journal-title":"Pharm Res (N Y)"},{"key":"10.1124\/dmd.106.013037_bib6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1124\/jpet.300.3.1036","article-title":"Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4","volume":"300","author":"Cummins","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.013037_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/jpet.103.058065","article-title":"CYP3A4-transfected Caco-2 cells as a tool for understanding biochemical absorption barriers: studies with sirolimus and midazolam","volume":"308","author":"Cummins","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.013037_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.physiol.66.032102.144149","article-title":"Molecular and integrative physiology of intestinal peptide transport","volume":"66","author":"Daniel","year":"2004","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/dmd.106.013037_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm Res (N Y)"},{"key":"10.1124\/dmd.106.013037_bib10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-3565(24)38246-1","article-title":"Midazolam metabolism by modified Caco-2 monolayers: effects of extracellular protein binding","volume":"289","author":"Fisher","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.013037_bib11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0090-9556(25)07487-2","article-title":"Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450","volume":"24","author":"Ghosal","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.013037_bib12","first-page":"798","article-title":"A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine","volume":"29","author":"Hashizume","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.013037_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1211\/0022357991771971","article-title":"Dose-dependent intestinal and hepatic first-pass metabolism of midazolam, a cytochrome P450 3A substrate with differently modulated enzyme activity in rats","volume":"51","author":"Higashikawa","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.106.013037_bib14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1124\/dmd.31.9.1151","article-title":"Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A","volume":"31","author":"Johnson","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.013037_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00498250410001685755","article-title":"Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans","volume":"34","author":"Kanazu","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.106.013037_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2133\/dmpk.18.1","article-title":"Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation","volume":"18","author":"Katsura","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.106.013037_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/0016-5085(92)90756-O","article-title":"Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia","volume":"102","author":"Kolars","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.106.013037_bib18","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI116064","article-title":"Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes","volume":"90","author":"Kolars","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.106.013037_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02246454","article-title":"Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics","volume":"126","author":"Lau","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/dmd.106.013037_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/jpet.301.2.586","article-title":"Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat","volume":"301","author":"Li","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.013037_bib21","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.013037_bib22","first-page":"14","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.106.013037_bib23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery","volume":"299","author":"Polli","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.013037_bib24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1359-6446(04)03198-8","article-title":"Transporter-mediated drug delivery: recent progress and experimental approaches","volume":"9","author":"Sai","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1124\/dmd.106.013037_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00498250600571749","article-title":"Marked species differences in the bioavailability of midazolam in cynomolgus monkeys and humans","volume":"36","author":"Sakuda","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.106.013037_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s002040050403","article-title":"Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans","volume":"71","author":"Shimada","year":"1997","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.106.013037_bib27","first-page":"179","article-title":"The absolute oral bioavailability of selected drugs","volume":"27","author":"Sietsema","year":"1989","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1124\/dmd.106.013037_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1124\/dmd.31.10.1214","article-title":"Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis","volume":"31","author":"Tam","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.013037_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0022-3565(24)37004-1","article-title":"Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters","volume":"283","author":"Tamai","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.013037_bib30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.2042-7158.1996.tb05904.x","article-title":"Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier","volume":"48","author":"Terao","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.106.013037_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0009-9236(96)90177-0","article-title":"Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism","volume":"59","author":"Thummel","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.106.013037_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/A:1023433502647","article-title":"Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate","volume":"20","author":"Tolle-Sander","year":"2003","journal-title":"Pharm Res (N Y)"},{"key":"10.1124\/dmd.106.013037_bib33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1016086003070","article-title":"Carrier-mediated intestinal transport of drugs","volume":"13","author":"Tsuji","year":"1996","journal-title":"Pharm Res (N Y)"},{"key":"10.1124\/dmd.106.013037_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00498250400028197","article-title":"Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human","volume":"35","author":"Ward","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.106.013037_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1124\/dmd.32.6.603","article-title":"A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance","volume":"32","author":"Ward","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.013037_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0169-409X(97)00041-0","article-title":"The barrier function of CYP3A4 and P-glycoprotein in the small bowel","volume":"27","author":"Watkins","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.106.013037_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm Res (N Y)"},{"key":"10.1124\/dmd.106.013037_bib38","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0090-9556(24)15229-4","article-title":"Characterization of human small intestinal cytochromes P-450","volume":"27","author":"Zhang","year":"1999","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624013734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624013734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.106.013037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:19:02Z","timestamp":1739895542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624013734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0090955624013734"],"URL":"https:\/\/doi.org\/10.1124\/dmd.106.013037","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric Intestinal First-Pass Metabolism Causes Minimal Oral Bioavailability of Midazolam in Cynomolgus Monkey","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.106.013037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}